HSPB6 and breast carcinoma: These include FAM183A, which is upregulated in breast cancer cells in response to Notch signaling [31]; MUC4, expressed in 95% of breast carcinomas [32]; HSPB6, which is downregulated in breast cancer [33, 34]; and CCL28, which promotes breast cancer proliferation, tumor growth and metastasis [35].